A usually benign tumor of the insulin-secreting cells of the pancreas.

Alternative Names

Insuloma; Islet cells adenoma

Causes, incidence, and risk factors

The pancreas is an organ in the abdomen that releases the hormone insulin. Insulin is required to regulate blood levels of the sugar glucose. Tumors of the pancreas that produce excessive amounts of insulin (hyperinsulinemia) are called insulinomas. High insulin levels cause hypoglycemia, or low blood glucose. Hypoglycemia caused by insulinomas may be mild and lead to symptoms such as anxiety and hunger, but patients are also at risk for severe hypoglycemia that can cause seizures, coma and even death. Insulinomas are rare tumors that occur in about 1 out of 250,000 people. They usually occur as single, small tumors in adults, though the majority of children with hyperinsulinemia do not have a discrete tumor. Five to ten percent of insulinomas are malignant. Patients diagnosed with multiple endocrine neoplasia, Type I (MENI), are at risk to develop insulinomas.

Signs and tests

Treatment

Surgery is the preferred treatment for insulinoma. The tumor is localized with diagnostic testing or surgical exploration. Solitary tumors are resected, but patients with multiple tumors usually require partial resection of the pancreas (partial pancreatectomy). At least 15% of the pancreas is left to avoid malabsorption due to lack of pancreatic enzymes. If no tumor is found at surgery or a patient is not a candidate for surgery, the drug diazoxide may be given to lower insulin secretion and avoid hypoglycemia. A diuretic is always given with this medication to avoid retaining too much salt. Medical treatment is also used to stabilize the person prior to surgery.

Expectations (prognosis)

Death may result from a severe hypoglycemic reaction or spread of malignant tumors to other organs (metastases).

Complications

Calling your health care provider

Prevention

There is no known way to prevent the development of an insulinoma.